Filing Details

Accession Number:
0001179110-10-005771
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-19 13:00:00
Reporting Period:
2010-03-18
Filing Date:
2010-03-19
Accepted Time:
2010-03-19 20:27:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1239142 David Owen 78 Narrow Street
Limehouse
London E14 8BP
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2010-03-18 5,616 $42.73 17,704 No 4 M Direct
Common Shares Without Par Value Acquisiton 2010-03-18 6,413 $37.42 24,117 No 4 M Direct
Common Shares Without Par Value Disposition 2010-03-18 100 $54.44 24,017 No 4 S Direct
Common Shares Without Par Value Disposition 2010-03-18 9,929 $54.44 14,088 No 4 S Direct
Common Shares Without Par Value Disposition 2010-03-18 100 $54.44 13,988 No 4 S Direct
Common Shares Without Par Value Disposition 2010-03-18 1,900 $54.44 12,088 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Disposition 2010-03-18 5,616 $0.00 5,616 $42.73
Common Shares Option (right to buy) Disposition 2010-03-18 6,413 $0.00 6,413 $37.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2001-04-27 2011-04-26 No 4 M Direct
0 2003-04-25 2013-04-24 No 4 M Direct
Footnotes
  1. Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.